Boehringer to Fund Commercialization of Propeller’s Digital Platform for Asthma, COPD | Pharma Hub | Scoop.it

Propeller Health, a digital health solution for respiratory medicine, and Boehringer Ingelheim Pharmaceuticals Inc., a global pharmaceutical company and leading provider of inhaled medications for serious respiratory diseases, today announced a first-of-its-kind commercial partnership that aims to use digital health tools and services to help people living with chronic obstructive pulmonary disease (COPD) and asthma better manage their disease.  This partnership further validates Propeller’s lead as the only digital health company with multiple industry partnerships across Pharma and device manufacturers (Aptar, GSK). 


Via Pharma Guy